2017
DOI: 10.1177/1178626417703995
|View full text |Cite
|
Sign up to set email alerts
|

The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity

Abstract: There is substantial evidence that the growth hormone (GH)/insulin-like growth factor (IGF) system is involved in the pathophysiology of obesity. Both GH and IGF-I have direct effects on adipocyte proliferation and differentiation, and this system is involved in the cross-talk between adipose tissue, liver, and pituitary. Transgenic animal models have been of importance in identifying mechanisms underlying these interactions. It emerges that this system has key roles in visceral adiposity, and there is a ratio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
30
0
5

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(42 citation statements)
references
References 182 publications
(219 reference statements)
1
30
0
5
Order By: Relevance
“…1C,D). In mammals, a decreased level of IGF-1 is commonly accompanied with obesity (Lewitt, 2017). In this study, Nile tilapia fed on the HFD for 4 weeks had decreased IGF-1 mRNA expression, increased weight gain and visceral fat deposition (Table S3), which induced obesity, consistent with previous findings in mammals.…”
Section: Results and Discussion Expression Analysis Of Igf-1 And Socssupporting
confidence: 91%
“…1C,D). In mammals, a decreased level of IGF-1 is commonly accompanied with obesity (Lewitt, 2017). In this study, Nile tilapia fed on the HFD for 4 weeks had decreased IGF-1 mRNA expression, increased weight gain and visceral fat deposition (Table S3), which induced obesity, consistent with previous findings in mammals.…”
Section: Results and Discussion Expression Analysis Of Igf-1 And Socssupporting
confidence: 91%
“…Among them, for example, the focus could be directed toward the complexity of the GH/IGF-1 system, consisting of GH, IGF-1, different binding proteins, and co-regulatory proteins; in such a system, several assays for the measurement of the unbound active fraction of IGF-1 have been proposed and applied, complicating the jigsaw [ 89 ]. Another missing piece of information is related to the role played by the IGFBPs with respect to the adipose tissue, through their IGF-dependent and/or IGF-independent actions ([ 128 ] and references therein). As for adiponectin, it is not known if and how the several circulating adiponectin oligomeric isoforms, from low to very high MW, could contribute differently to the modulation of the GH/IGF-1 system.…”
Section: Discussionmentioning
confidence: 99%
“…Although obese individuals have lower GH production, their circulating IGF-1 concentrations were high, which could be explained by increased pre-adipocyte expression of IGF-1 and its receptor due to the effects of insulin and cortisol; thus, IGF-1 activates the proliferation of pre-adipocytes and their differentiation into adipocytes. 41 IGF-1 production in response to an increased number of adipocytes may play a role in the decreased output of GH observed in patients who suffer from obesity. 20,42,43 However, this decrease in the secretion of this hormone is not associated with an alteration in the speed of growth, since obese children usually have a normal or even increased height for their age; for example, in this study, the obese group was 7cm taller than children of similar age with adequate weight.…”
Section: Discussionmentioning
confidence: 99%